These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33726944)

  • 1. Anti-GM2 antibody positive Guillain-Barré syndrome presenting with ataxia in a pediatric patient: An atypical manifestation.
    Deliceo Göbüt E; Us Ö; Işık U
    Brain Dev; 2021 Jun; 43(6):729-733. PubMed ID: 33726944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
    Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
    Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
    Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-CMV Guillain-Barré Syndrome with Anti-GM2 Antibodies: Two Cases and a Review of the Literature.
    Manaud A; Geraudie A; Viguier A; Mengelle C; Fortenfant F; Baudou E; Cheuret E
    Neuropediatrics; 2022 Aug; 53(4):235-238. PubMed ID: 35716658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome following hepatitis E.
    Loly JP; Rikir E; Seivert M; Legros E; Defrance P; Belaiche J; Moonen G; Delwaide J
    World J Gastroenterol; 2009 Apr; 15(13):1645-7. PubMed ID: 19340910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.
    Irie S; Saito T; Kanazawa N; Ogino M; Ogino Y; Sakai F
    Intern Med; 2003 Jun; 42(6):490-5. PubMed ID: 12857046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.
    Cronin S; McNicholas R; Kavanagh E; Reid V; O'Rourke K
    Ir J Med Sci; 2011 Mar; 180(1):255-7. PubMed ID: 21063804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever.
    Prado MB; Narito KM; Adiao KJB
    J Neuroimmunol; 2021 Jun; 355():577572. PubMed ID: 33862418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC; van Doorn PA; Groeneveld JH; Tio-Gillen AP; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):641-3. PubMed ID: 9219756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome.
    Kim SY; Kim JK; Suh CK
    J Clin Neurosci; 2013 Mar; 20(3):473-5. PubMed ID: 23164827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination.
    Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T
    Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.
    Kim JK; Kim YH; Yoon BA; Cho JY; Oh SY; Shin HY; Kim JS; Park KH; Kim SY; Suh BC; Seok HY; Yoo JH; Bae JS
    J Clin Neurol; 2018 Jul; 14(3):401-406. PubMed ID: 29971981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Irie S; Saito T; Nakamura K; Kanazawa N; Ogino M; Nukazawa T; Ito H; Tamai Y; Kowa H
    J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    J Neuroimmunol; 2001 Feb; 113(2):260-7. PubMed ID: 11164910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.